|
1
|
von Dadelszen P, Magee LA and Roberts JM:
Subclassification of preeclampsia. Hypertens Pregnancy. 22:143–148.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walker JJ: Pre-eclampsia. Lancet.
356:1260–1265. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wagner LK: Diagnosis and management of
preeclampsia. Am Fam Physician. 70:2317–2324. 2004.PubMed/NCBI
|
|
4
|
Report of the National high blood pressure
education program working group on high blood pressure in
pregnancy. Am J Obstet Gynecol. 183:S1–S22. 2000. View Article : Google Scholar
|
|
5
|
Wagner SJ, Barac S and Garovic VD:
Hypertensive pregnancy disorders: Current concepts. J Clin
Hypertens (Greenwich). 9:560–566. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuklina EV, Ayala C and Callaghan WM:
Hypertensive disorders and severe obstetric morbidity in the United
States. Obstet Gynecol. 113:1299–1306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aneman I, Pienaar D, Suvakov S, Simic TP,
Garovic VD and McClements L: Mechanisms of key innate immune cells
in early- and late-onset preeclampsia. Front Immunol. 11:18642020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Redman CW and Sargent IL: Latest advances
in understanding preeclampsia. Science. 308:1592–1594. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Norwitz ER, Hsu CD and Repke JT: Acute
complications of preeclampsia. Clin Obstet Gynecol. 45:308–329.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karumanchi SA, Maynard SE, Stillman IE,
Epstein FH and Sukhatme VP: Preeclampsia: A renal perspective.
Kidney Int. 67:2101–2113. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Say L, Chou D, Gemmill A, Tunçalp Ö,
Moller AB, Daniels J, Gülmezoglu AM, Temmerman M and Alkema L:
Global causes of maternal death: A WHO systematic analysis. Lancet
Glob Health. 2:e323–e333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lisonkova S and Joseph KS: Incidence of
preeclampsia: Risk factors and outcomes associated with
early-versus late-onset disease. Am J Obstet Gynecol.
209:544.e1–544.e12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Basso O, Rasmussen S, Weinberg CR, Wilcox
AJ, Irgens LM and Skjaerven R: Trends in fetal and infant survival
following preeclampsia. JAMA. 296:1357–1362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Backes CH, Markham K, Moorehead P, Cordero
L, Nankervis CA and Giannone PJ: Maternal preeclampsia and neonatal
outcomes. J Pregnancy. 2011:2143652011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burton GJ, Redman CW, Roberts JM and
Moffett A: Pre-eclampsia: Pathophysiology and clinical
implications. BMJ. 366:l23812019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rolfo A, Many A, Racano A, Tal R,
Tagliaferro A, Ietta F, Wang J, Post M and Caniggia I:
Abnormalities in oxygen sensing define early and late onset
preeclampsia as distinct pathologies. PLoS One. 5:e132882010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sezer SD, Küçük M, Döger FK, Yüksel H,
Odabaşı AR, Türkmen MK, Cakmak BÇ, Ömürlü İK and Kınaş MG: VEGF,
PIGF and HIF-1α in placentas of early- and late-onset pre-eclamptic
patients. Gynecol Endocrinol. 29:797–800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hoek RM, Ruuls SR, Murphy CA, Wright GJ,
Goddard R, Zurawski SM, Blom B, Homola ME, Streit WJ, Brown MH, et
al: Down-regulation of the macrophage lineage through interaction
with OX2 (CD200). Science. 290:1768–1771. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang S, Cherwinski H, Sedgwick JD and
Phillips JH: Molecular mechanisms of CD200 inhibition of mast cell
activation. J Immunol. 173:6786–6793. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Zhang D, Xu L, Dong L, Zheng J, Lin
Y, Huang J, Zhang Y, Tao Y, Zang X, et al: Cell-cell contact with
proinflammatory macrophages enhances the immunotherapeutic effect
of mesenchymal stem cells in two abortion models. Cell Mol Immunol.
16:908–920. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu J, Gu Y, Sun J, Zhu H, Lewis DF and
Wang Y: Reduced CD200 expression is associated with altered Th1/Th2
cytokine production in placental trophoblasts from preeclampsia. Am
J Reprod Immunol. 79:110.1111/aji.12763. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
ACOG Committee on Obstetric Practice, .
ACOG practice bulletin. Diagnosis and management of preeclampsia
and eclampsia. Number 33, January 2002. American college of
obstetricians and gynecologists. Int J Gynaecol Obstet. 77:67–75.
2002.PubMed/NCBI
|
|
23
|
Ryota H, Ishida M, Satoi S, Yanagimoto H,
Yamamoto T, Kosaka H, Hirooka S, Yamaki S, Kotsuka M, Matsui Y, et
al: Clinicopathological and immunological features of follicular
pancreatitis-a distinct disease entity characterised by Th17
activation. Histopathology. 74:709–717. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Egbor M, Ansari T, Morris N, Green CJ and
Sibbons PD: Morphometric placental villous and vascular
abnormalities in early- and late-onset pre-eclampsia with and
without fetal growth restriction. BJOG. 113:580–589. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van der Merwe JL, Hall DR, Wright C,
Schubert P and Grové D: Are early and late preeclampsia distinct
subclasses of the disease-what does the placenta reveal? Hypertens
Pregnancy. 29:457–467. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Staff AC: The two-stage placental model of
preeclampsia: An update. J Reprod Immunol. 134–135. 1–10.
2019.PubMed/NCBI
|
|
28
|
Miller D, Motomura K, Galaz J, Gershater
M, Lee ED, Romero R and Gomez-Lopez N: Cellular immune responses in
the pathophysiology of preeclampsia. J Leukoc Biol. 111:237–260.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dekker GA and Sibai BM: Etiology and
pathogenesis of preeclampsia: Current concepts. Am J Obstet
Gynecol. 179:1359–1375. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Enquobahrie DA, Meller M, Rice K, Psaty
BM, Siscovick DS and Williams MA: Differential placental gene
expression in preeclampsia. Am J Obstet Gynecol. 199:566.e1–11.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shibata E, Rajakumar A, Powers RW, Larkin
RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM and
Hubel CA: Soluble fms-like tyrosine kinase 1 is increased in
preeclampsia but not in normotensive pregnancies with
small-for-gestational-age neonates: Relationship to circulating
placental growth factor. J Clin Endocrinol Metab. 90:4895–4903.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang LQ, Yan CF, Zhao Y, Chu J and Yu XW:
Reduced CD200 and CD200R1 expression in human chorionic villi
contributes to early spontaneous abortion. Acta Obstet Gynecol
Scand. 93:1248–1254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van 't Hof LJ, Dijkstra KL, van der Keur
C, Eikmans M, Baelde HJ, Bos M and van der Hoorn MLP: Decreased
expression of ligands of placental immune checkpoint inhibitors in
uncomplicated and preeclamptic oocyte donation pregnancies. J
Reprod Immunol. 142:1031942020. View Article : Google Scholar : PubMed/NCBI
|
